EP1181060A1 - Molded implants for orthopedic applications - Google Patents

Molded implants for orthopedic applications

Info

Publication number
EP1181060A1
EP1181060A1 EP00917954A EP00917954A EP1181060A1 EP 1181060 A1 EP1181060 A1 EP 1181060A1 EP 00917954 A EP00917954 A EP 00917954A EP 00917954 A EP00917954 A EP 00917954A EP 1181060 A1 EP1181060 A1 EP 1181060A1
Authority
EP
European Patent Office
Prior art keywords
implant
bone
shaped
useful
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00917954A
Other languages
German (de)
French (fr)
Inventor
John F. Wironen
Jeffrey Horn
Penelope Kao
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Regeneration Technologies Inc
Original Assignee
Regeneration Technologies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneration Technologies Inc filed Critical Regeneration Technologies Inc
Priority claimed from PCT/US2000/006773 external-priority patent/WO2000054821A1/en
Publication of EP1181060A1 publication Critical patent/EP1181060A1/en
Withdrawn legal-status Critical Current

Links

Definitions

  • This invention relates to an implant and methods for making and using the implant to fill void defects in bone and to accomplish orthopedic fusions.
  • the filling of bone defects was usually accomplished through the use of metallic fixation and reinforcement devices or the combination of metallic devices with autograft or allograft.
  • Recurrent problems in the methods known in the art are the lack of incorporation of the metallic graft materials, the pain associated with autograft harvest, the lack of sufficient amounts of autograft for harvesting, the labor-intensive nature of autograft and allograft preparation, and the relatively poor performance of commonly acquired allografts.
  • a recurring problem in the methods known in the art for repairing, for example, the acetabular surface is that frequently, upon insertion into the acetabulum of metallic or polymeric implant materials, voids remain between the back surface of the implant and the pelvic bone remaining in the original femoral socket.
  • cortical cancellous chips combined with metallic mesh and circlage wires have been used successfully to fill voids in the acetabulum and proximal femur, and while incorporation of bone chips and de novo bone formation at the impaction grafting site has been observed, cortical-cancellous chips handle poorly. The chips tend to behave like gravel and do not stay in the location into which they are placed unless enclosed by wire mesh or another retaining device. Furthermore, when methyl methacrylate or like cement is pressurized in impaction grafting, large amounts of bone chips become sequestered and therefore are biologically inactive.
  • the impaction procedure itself requires specialized equipment (such as the rack-and-pinion device to which the 5,824,078 patent is directed) or time consuming in-surgery impaction of bone particles (see the Elting et al., article, which describes a six-step, in-situ, procedure which requires iterative packing and tamping of bone particles).
  • This invention provides a solution to the above-noted, long-standing problems by providing specific shapes and compositions of biomaterials for filling of tissue voids, in particular in bony tissue, in an easy to use and effective format.
  • Figure 1 is a representation of a first embodiment of the invention, wherein a disk-shaped bioimplant is provided for insertion into the acetabular socket or other location to fill voids that remain upon insertion of a metallic or other implant.
  • Figure 2 A is a representation of a second embodiment of the invention, wherein a substantially disk-shaped bioimplant is provided, but wherein a sector of the disk- shaped implant has either been removed or has not been included when initially created, so that upon insertion into the acetabluar socket, a substantially cone- shaped or hemisphere-shaped implant, figure 2B, is formed.
  • Figure 3 provides representations of a number of further embodiments of the invention: Fig.
  • FIG. 3 A depicts a thin "U"-shaped implant useful in knee revision surgeries
  • Fig. 3B depicts a thicker "U”-shaped implant useful in spinal fusion procedures
  • Fig. 3C depicts a thin oval implant useful in knee revision and other surgical procedures
  • Fig. 3D depicts an implant shape useful in posterior lumbar interbody fusion ("PLIF") procedures
  • Fig. 3E depicts a dowel shaped implant, useful in spinal and joint fusions
  • Fig. 3F depicts a tapered dowel shaped implant, useful in spinal and joint fusions.
  • PLIF posterior lumbar interbody fusion
  • Figure 4 provides representations of a number of further embodiments of the invention: Fig. 4A depicts a femoral or tibial ring shaped implant useful in interbody fusion procedures; Fig. 4B depicts a round, plug-shaped implant useful in cranial burr-hole repairs; Fig. 4C depicts a thin "U"-shaped implant which may be folded to provide a cone-shaped or hemisphere-shaped implant depicted in Fig. 4D, useful in knee replacement procedures; Fig. 4E depicts a thin embodiment of the implant depicted according to figure 2, and Fig. 4F depicts the implant when it is folded onto itself to form a cone or hemisphere, useful in acetabular cup reconstruction and other procedures.
  • Figure 5 provides representations of a number of further embodiments of the invention:
  • Fig. 5 A depicts an implant similar to that shown in figures 2 and 4A, except that an asymmetric sector has been removed or excluded from the otherwise circular implant shape;
  • Fig. 5B depicts the implant of Fig. 5 A when folded upon itself to form a cone, or hemisphere, useful in acetabular cup and like reconstructions;
  • Fig. 5C depicts a "donu '-shaped implant comprising a flat circular implant having a co-axial void, useful in acetabular cup reconstruction and like procedures where the implant is molded or press-fit to the void space;
  • Fig. 5 A depicts an implant similar to that shown in figures 2 and 4A, except that an asymmetric sector has been removed or excluded from the otherwise circular implant shape
  • Fig. 5B depicts the implant of Fig. 5 A when folded upon itself to form a cone, or hemisphere, useful in acetabular cup and like reconstructions
  • FIG. 5D depicts a hemi-shell shaped implant which may be press-fit into a bone void, such as in the acetabular cup
  • Fig. 5E depicts a cone-shaped or hemisphere- shaped implant which may be press-fit into a bone void, such as in the acetabular cup
  • Fig. 5F depicts a tube which, depending on diameter, may be press-fit or used in an impaction grafting procedure in a bone intrameduUary canal
  • Fig. 5G depicts a nested pair of tubes or cones which may be used for repair of large femoral defects, optionally in association with impaction grafting procedures.
  • Figure 6 provides representations of a number of further embodiments of the invention: Fig.
  • FIG. 6 A depicts a sheet while Fig. 6B depicts a strip for repair of traumatic fractures, for cranial and flat-bone repair applications, and for inter- transverse process fusions;
  • Fig. 6C depicts a cord-shaped implant for wrapping or grouting of severe trauma defects, for spinal fusions, inter-transverse process fusions and the like;
  • Fig. 6D depicts a wedge-shaped implant for tibial plateau repairs, joint fusions, and intervertebral body fusions;
  • Figs. 6E, 6F and 7 depict different embodiments of restrictive devices, useful in restricting cement or other flowable materials in plugged intrameduUary canals and the like, as in femoral canals during impaction procedures;
  • Fig. 6A depicts a sheet while Fig. 6B depicts a strip for repair of traumatic fractures, for cranial and flat-bone repair applications, and for inter- transverse process fusions;
  • Fig. 6C depicts a
  • FIG. 6G depicts an ovoid or football shaped implant useful in repairing cystoid or like bone defects
  • Fig. 6H depicts a hemi- ovoid or hemi-football shaped implant useful in repairing cystoid or like bone defects
  • Fig. 61 depicts a spherical implant useful in repairing cystoid or like bone defects
  • Fig. 6J depicts a hemi-spherical implant useful in repairing cystoid or like bone defects.
  • Figure 7 depicts an implant useful as a restrictive device for insertion into a canal, such as the intrameduUary canal of a long bone, for example during a cementous impaction procedure.
  • Figures 8A-C provide X-ray evidence of the efficacy of an acetabular implant according to this invention.
  • Figures 9A-10 provide photomicrographs of the composition of this invention, before and after implantation.
  • Figures 10A-D provide further photomicrographs of the composition of this invention, before and after implantation.
  • Figures 11A-H provides a series of photographs and X-rays showing repair of a severe tibial complex compound fracture after removal of antibiotic loaded methacrylate beads and implantation of the composition according to this invention.
  • Figure 12 A and 12B provide photographs of one embodiment of the implant according to this invention, and its moldability.
  • This invention provides shaped implants and methods for making and using the implants to repair a wide variety of orthopedic defects or lesions, including, for example, acetabular cup damage or repair procedures.
  • the implant may be made from any of a number of known materials, by employing the specific shapes and methods provided herein. Alternatively, specific novel compositions disclosed herein may be used for this purpose.
  • the implant is placed in the acetabular socket or other defect requiring repair, and is molded to create a perfect fit between an overlay implant to be inserted into the acetabulum and the bone surface of the pelvis or other overlay implant and basal bony structure. Accordingly, it is one object of this invention to provide a wide variety of desirably shaped implants for a wide variety of orthopedic applications.
  • the composition should be bioabsorbable. b.
  • the composition should be osteogenic.
  • the composition should be osteoinductive.
  • the composition should be osteoconductive.
  • the composition should be malleable or flexible prior to and shortly after implantation so that any desired shape may be produced.
  • the composition should be able to withstand freezing, freeze-drying or other methods of preservation and be able to withstand sterilization.
  • the materials should fill voids and, if malleable prior to implantation, should then set-up as a hard material in the shape of the voids that have been filled.
  • the device 100 is substantially disk-shaped, having an upper surface 101, a lower surface 102, each of which is substantially circular, with a diameter 110.
  • the diameter 110 is preferably in the range between about 35 and 55 mm, and most preferably is about 45 mm.
  • the disk 100 has a height 120, which is preferably in the range between about 1 mm and about 10 mm, and is most preferably about 5 mm in height.
  • the disk 100 may be composed of particulate matter 130 embedded or suspended in a base or carrier material 140.
  • the particulate matter may be collagen sponge, cortical bone chips, cancellous bone chips, cortico-cancellous bone chips, hydroxyapatite or like ceramics, bioactive glass, growth factors, including but not limited to bone morphogenetic protein, PDGF, TGF ⁇ , cartilage-derived morphogenetic proteins (CDMPs), vascular growth factors, and the like, deminerahzed bone, or any other material considered to be beneficial in the filling of bone or cartilaginous voids and the remodeling thereof into solid, healthy bone or cartilage through the processes of osseointegration (including osteogenesis, osteoinduction, or osteoconduction, as these terms are recognized in the art).
  • growth factors including but not limited to bone morphogenetic protein, PDGF, TGF ⁇ , cartilage-derived morphogenetic proteins (CDMPs), vascular growth factors, and the like, deminerahzed bone, or any other material considered to be beneficial in the filling of bone or cartilaginous voids and the remodeling thereof into solid, healthy bone or
  • the base or carrier material 140 may be any material, which retains a given form upon implantation into the void being filled behind an acetabular implant or in any other orthopedic application.
  • fibrin-containing compositions which coagulate, may be included in the carrier material 140, as may be various collagen formulations, hydroxylapatite, pleuronic polymers, natural or synthetic polymers, or carboxymethylcellulose, and combinations thereof.
  • the carrier material 140 comprises a sufficiently high concentration of gelatin, derived from human or animal tissue, or transgenic sources, such that prior to or upon implantation, the gelatin sets up to form a solid or semi-solid material of the desired shape.
  • Use of gelatin as the base carrier material is considered desirable because, by simply heating a pre-formed device according to any of the embodiments of this invention, the implant device becomes flexible or malleable, and may be caused to precisely fit into the shape of any existing void or defect.
  • the gelatin is preferably present at between about 12 to 27 weight percent.
  • Deminerahzed bone is preferably present at between about 15 to 33 weight percent.
  • cancellous bone chips, cortical bone chips or cortico-cancellous bone chips are preferably present at between about 70 to 100 volume percent. The bone chips soak up the gelatin/demineralized bone material so that approximately equal volumes of the gelatin/demineralized bone and bone chips are preferably combined to produce the final preferred composition.
  • compositions formed from this composition meet all of the requirements of a desirable implant material set forth above.
  • supplemental constituents may be included in the composition.
  • growth factors, antibiotics, anti-inflammatory or other biologically active agents may be included at percentages that may be defined through routine experimentation, so long as the basic properties of the implant material is not adversely affected.
  • a composition that is malleable above body temperature may be produced.
  • deminerahzed bone to provide osteogenic factors
  • cortical-cancellous bone chips to provide structural strength and bone void filling capacity
  • FIG 2A there is shown a further embodiment 200 of the device according to this invention.
  • This device is similar to that shown in figure 1, in that it has an upper surface 201, a lower surface 202, both of which are substantially circular.
  • a sector 203 has been removed or has not been included in the formation of the device, resulting in what will be referred to herein as a "filled-C-shape".
  • the purpose of this design modification is discussed in connection with the description of figure 2B below.
  • the composition of the device shown in figure 2A and that of figure 1 may be similar, as are its desirable characteristics.
  • the diameter 210 of the device 200 is preferably between about 50 mm and about 150 mm, and is most preferably between about 75 mm and 90 mm.
  • the height 220 of the device is between about 1 mm and about 10 mm, and is most preferably about 5 mm.
  • the particulate materials 230 when included, are similar to the particulate materials 130.
  • the base or carrier material 240 is likewise similar to the carrier or base material 140.
  • the angle formed between the adjacent sides 204 and 205 of the device 200 that exist by virtue of the absent sector 203 may be any angle greater than zero degrees and less than three-hundred and sixty degrees, and is preferably between about 90 and 150 degrees, and is most preferably about 120 degrees.
  • FIG 2B there is shown the device 200, wherein the adjacent sides 204 and 205 have been brought into contact, to form a substantially cone-shaped or hemisphere-shaped implant 260.
  • the device retains thermoplastic behavior for a limited amount of time after formation, so that the desired shape may be formed from the cone-shaped implant 260.
  • Figure 3 provides representations of a number of further embodiments of the invention: Fig. 3 A depicts a thin "U"- shaped implant 300 useful in knee revision surgeries. Fig. 3B depicts a thicker "U"-shaped implant 310 useful in spinal fusion procedures. Fig. 3C depicts a thin oval implant 320 useful in knee revision and other surgical procedures. Fig. 3D depicts an implant shape 330 useful in posterior lumbar interbody fusion ("PLIF”) procedures. Fig.
  • PLIF posterior lumbar interbody fusion
  • FIG. 3E depicts a dowel shaped implant 340, useful in spinal and joint fusions.
  • Fig. 3F depicts a tapered dowel shaped implant 350, useful in spinal and joint fusions.
  • various percentages of particulate materials may be included in each of these disclosed shapes, as defined by routine experimentation, for particular applications.
  • methods for conducting posterior lumbar interbody fusions, spinal fusions induced by dowels and the like may be carried out according to methods known in the art, but using the novel devices disclosed herein.
  • FIG. 4A depicts a femoral or tibial ring shaped implant 400 useful in interbody fusion procedures.
  • FIG. 4B depicts a round, plug-shaped implant 410 useful in cranial burr-hole repairs.
  • Fig. 4C depicts a thin "U"-shaped implant 420 which may be folded to provide a cone- shaped or hemisphere-shaped implant 430 depicted in Fig. 4D, useful in knee replacement procedures.
  • Fig. 4E depicts a thin embodiment 440 of the implant depicted according to figure 2
  • Fig. 4F depicts the implant 450 when it is folded onto itself to form a cone, or hemisphere, useful in acetabular cup reconstruction and other procedures.
  • FIG. 5A depicts an implant 510 similar to that shown in figures 2 and 4A, except that an asymmetric sector 511 has been removed or excluded from the otherwise circular implant shape.
  • Fig. 5B depicts the implant of Fig. 5 A when folded upon itself to form a cone or hemisphere 520, useful in acetabular cup and like reconstructions.
  • Fig. 5C depicts a "donu '-shaped implant 530 comprising a flat circular implant having a co-axial void, useful in acetabular cup reconstruction and like procedures where the implant is molded or press-fit to the void space.
  • Fig. 5A depicts an implant 510 similar to that shown in figures 2 and 4A, except that an asymmetric sector 511 has been removed or excluded from the otherwise circular implant shape.
  • Fig. 5B depicts the implant of Fig. 5 A when folded upon itself to form a cone or hemisphere 520, useful in acetabular cup and like reconstructions.
  • Fig. 5C depicts a
  • FIG. 5D depicts a hemi-shell shaped implant 540 which may be press-fit into a bone void, such as in the acetabular cup.
  • Fig. 5E depicts a cone-shaped or hemisphere-shaped implant 550, which may be press-fit into a bone void, such as in the acetabular cup.
  • Fig. 5F depicts a tube 560 which, depending on diameter, may be press-fit or used in an impaction grafting procedure in a bone intrameduUary canal.
  • Fig. 5G depicts a nested pair of tubes or cones 570, which may be used for repair of large femoral defects, optionally in association with impaction grafting procedures.
  • Each of these shapes may be fashioned by hand, molded, extruded or formed by other means known in the art.
  • solid materials may be machined to produce the desired shapes, or because of the thermoplastic properties of gelatin, the desired shapes may be produced by known stereolitho graphic processes.
  • FIG. 6A depicts a sheet 600 while Fig. 6B depicts a strip 610 for repair of traumatic fractures, for cranial and flat- bone repair applications, and for inter-transverse process fusions.
  • Fig. 6C depicts a cord-shaped implant 620 for wrapping or grouting of severe trauma defects, for spinal fusions, inter-transverse process fusions and the like.
  • Fig. 6D depicts a wedge-shaped implant 630 for tibial plateau repairs, joint fusions, and intervertebral body fusions; Figs.
  • 6E, 6F and 7 depict different embodiments of restrictive devices, 640, 650, 700, useful in restricting cement or other flowable materials in plugged intrameduUary canals and the like, as in femoral canals during impaction procedures.
  • the flow restrictor 640 has a classic "cork” stopper shape.
  • the implant 650 has a tapered shape like that of the "cork” 640, but the device 650 is formed by a plurality of stacked "ribs" 651-655 of decreasing diameter. Naturally, the ribs may be formed by molding, such that separate elements 651-655 need to be separately produced.
  • the implant 700 comprises an upper, solid portion 710 having a substantially "cork" shaped configuration.
  • Fig. 6G depicts an ovoid or football shaped implant 660 useful in repairing cystoid or like bone defects.
  • Fig. 6H depicts a hemi-ovoid or hemi-football shaped implant 670 useful in repairing cystoid or like bone defects.
  • Fig. 61 depicts a spherical implant 680 useful in repairing cystoid or like bone defects.
  • Fig. 6J depicts a hemi-spherical implant 690 useful in repairing cystoid or like bone defects.
  • a revision surgery was indicated to replace the worn acetabular component and to remove the lesion.
  • the bone lesion was curetted out leaving a healthy bleeding bone mass.
  • a cone- or hemisphere-shaped device was made from 100% v/v cortical-cancellous chips mixed with 68% v/v deminerahzed bone matrix in a gelatin carrier (24% w/w deminerahzed bone matrix, 26% w/w gelatin, 50% w/w water) was heated to soften the implant, which was then folded to form a cone or hemisphere.
  • Figure 8B shows an immediate post-operative X-ray, showing the implant with the above-described composition located where the osteolytic defect existed.
  • Figure 8C shows the same patient six months after completion of the osteolytic defect repair operation. Growth of new bone and repair of the defect is clearly evident.
  • Example 2 PLACEMENT OF A PRIMARY HIP ACETABULAR CUP:
  • Press-fit implants are used in younger patients because the long-term success of these implants is improved over those that are cemented into place using methacrylate bone cement. The reason for this improved long-term success is that the bone directly bonds to the surface of the implant. Because bone-to-implant bonding is improved by the incorporation of a porous coat in the implant, most press-fit orthopedic implants now have a porous coating. However, even with a porous coating, after explantation, most implants are found to only have bonded to the bone over approximately 20% of the surface area. Research has also shown that the long-term success of the implant is roughly correlated with degree of host- implant bonding. The degree of host-implant bonding is severely affected by the quality of the fit between the bone and the implant.
  • the osteoinductive, osteoconductive or osteogenic matrix according to this invention which closely and concurrently interdigitates with both the porous surface of the implant and the bone into which the implant is inserted, facilitates repair of even poorly cut cavities in bone for press-fit insertion of implants. Interdigitation between the porous implant surface and bone causes bone to be induced or conducted from the bleeding bone into the porous coating and thereby induce much better bone-implant bonding.
  • a young, otherwise healthy, patient presenting with osteoarthritis of the hip is treated as follows: It is noted that the degree of advancement of osteoarthritic bone destruction is such that drug-therapy is insufficient to relieve pain and the patient has limited mobility.
  • a primary press-fit hip replacement is indicated. Through standard surgical techniques, the natural hip is removed and prepared for replacement with a metallic hip. The acetabulum is prepared by carefully reaming out a space that fits to the back of the acetabulum. A doughnut-shaped acetabular implant (Fig. 4 A or 5C) is prepared by warming in a water bath. The warm doughnut-shaped implant is placed into the patient's prepared acetabulum.
  • the porous acetabular cup is placed on top of the doughnut- shaped implant and is hammered into place.
  • the particle size and viscosity of the doughnut- shaped implant material allows the material to easily flow into the porous coating of the implant and into the host's cancellous bone.
  • Figure 9A shows a photomicrograph (40-X) of stained (H&E) composition according to this invention. Based on the staining, the different components of this composition are identified. Note the preferred relative uniformity, preferably between about 125 ⁇ m to about 5mm, and preferably, between about 500 ⁇ m to about 1 mm or between about 1mm to about 3.35 mm. We have found that bone chips uniformly formed within these preferred size ranges result in surprisingly improved induction and conduction of new bone formation and improved handling of the composition.
  • FIG 9B the same material is viewed under higher magnification (100X), showing the interpenetration of gelatin into and onto the cortical-cancellous chips and deminerahzed bone matrix of the composition.
  • Figure 9C shows a biopsy after implantation of this composition in a human female, 6 months after implantation, showing new bone formed onto the surface of a piece of allograft (H&E, 100X). Noticeable are the numerous cutting cones within the mineralized allograft, indicating that the allograft bone will continue to be fully remodeled over time.
  • Figure 9D shows a biopsy of new woven bone between mineralized allograft chips (H&E, 100X). It should be noted that the area between the spicules would normally be filled with healthy marrow. However, in this case, it can be seen that these areas are filled with fibrous inflammatory tissue cause by wear debris from a failed prosthesis.
  • FIG 10A shows additional photomicrographs of a biopsy from a human female six months after implantation of the composition of this invention. This photograph shows details of a cutting cone in a piece of mineralized allograft (H&E, 400X), revealing the presence of osteoclasts, osteoblasts and a cement line, whereby implant material is remodeled into normal healthy recipient bone.
  • Figure 10B shows a detailed photomicrograph of a cement line between mineralized allograft and new bone (H&E, 400X), revealing osteoblasts at the periphery of the allograft.
  • Figure IOC is a photomicrograph of normal marrow found in areas adjacent newly formed bone, unaffected by wear debris (H&E, 400X).
  • Figure 10D provides a detail of the filamentous wear debris found in the fibrous inflammatory tissue (H&E, 400X).
  • a porous implant or an implant having a porous coating is contacted with the composition according to this invention.
  • an implant having 500-700 ⁇ m metal beads contacted with the sawn-off end of the femur typically an implant having 500-700 ⁇ m metal beads contacted with the sawn-off end of the femur.
  • a complex fracture such as one in the radius, is repaired by following standard surgical techniques to clean the fracture site followed by placement within the fracture of malleable allograft implant material of this invention in the form of a football, sphere, hemi-football, hemisphere, or sheet/strip.
  • Shattered bone particles are packed around the malleable material.
  • the shattered particles of bone are placed into the fracture site and then strips or cords of malleable implant material according to this invention are laid over the fracture site.
  • Malleable cord-shaped implant material of this invention is optionally used as an adjunct or in place of circlage wires to fix the fracture fragments into place.
  • Figure 11 shows a surgical procedure in a tibia of a patient who experienced a complex compound fracture into which, for a period of four weeks, had been implanted gentamycin impregnated polymethylmethacrylate "beads on a string".
  • Figure 11 A shows circular structures in the center of the photograph which are the beads, implanted in an effort to treat a local infection at a fracture site.
  • Figure 1 IB shows a pre-operative X-ray of the surgical set-up, again with the implanted beads visible in the bone void.
  • Figure 11C shows the intra-operative procedure whereby the implanted beads were removed.
  • Figure 1 ID shows the large cavity remaining after removal of the beads.
  • Figure 1 IE shows a photograph of the composition according to this invention, formed in the shape of two dry eight cubic centimeter disks, prior to implantation.
  • Figure 1 IF is an intra-operative photograph, after implantation of sixteen cubic centimeters of the composition of this invention.
  • the implant material is clearly visible, and as can be seen from this photograph, is moistened by body fluids, but is not soluble and is not washed away.
  • Figure 11G shows the implant site immediately post-implantation. The site of the implant within the void can be discerned as a faint cloud within the void.
  • Figure 11H is an X-ray photograph of the implant site six-weeks post implantation. It can clearly be seen that the implant material has remodeled to form solid bone mass, while a portion of the void into which implant material was not or could not be implanted remains a void.
  • Osteolytic cysts and other growths on bone that must be removed are typically difficult to replace. Traditional practice dictates that large cystic defects be filled with weight- bearing allograft or autograft. Alternative techniques have employed synthetic materials with limited success.
  • cystic defects are repaired after removal of the cyst by placing warm, malleable implant material according to this invention onto the defect and forming it to completely fill the void.
  • the material according to a preferred embodiment of this invention remodels into natural bone in a period ranging from between about 6 weeks to about 9 months.
  • Intertransverse process spinal fusion is generally accomplished by the joint application of both metallic fixation devices and the use of autograft, which is generally harvested from the patient's hip.
  • autograft which is generally harvested from the patient's hip.
  • the autograft harvest is associated with a high rate of morbidity (21%).
  • the use of a grafting material that is effective without the necessity of harvesting autograft would greatly benefit patients in need of such procedures.
  • a malleable pre-molded form (strips or cords) of the malleable implant material of this invention are lain gutter alongside the vertebral bodies.
  • Local bone reamings are optionally mixed or intermingled with the still warm and malleable implant material and then the implant material is pressed into the bleeding bone bed.
  • Example 6 FILLING OF CRANIAL BURR HOLES:
  • Cranial burr-holes are created whenever it is necessary to cut into the skull in order to gain access to the brain.
  • Current technique dictates the use of plaster of paris-like substances, metallic meshes, and bone waxes to fill these holes, or to not fill them at all. None of the commonly employed products and procedures induce bone to grow across the defect, and some of these products and procedures actually inhibit the growth of the bone.
  • a disk-shaped piece of pre-molded implant material according to this invention is placed, warm, into the burr-hole defect, with a small lip of the implant material remaining above the surface to serve as a temporary support for the material. It is anticipated that the temporary support is unnecessary after a period of several days, after which the plug is expected to remain in place on its own. It is anticipated that new bone grows into the remaining gap to completely bridge the gap within about 6 weeks to about 9 months.
  • Figure 12 shows the formability and moldability of the composition of this invention.
  • Figure 12A shows a dry cone or hemisphere of the composition. Upon hydration and heating to about 43 to about 49 degrees centigrade, the material becomes moldable, and re-sets at body temperature, as shown in figure 12B, where the moldable material is being press-fit by finger pressure into a cavity. Once set-up, the material is easily reamed or drilled for placement of any desired prosthesis.
  • Example 8 PRODUCTION OF CORTICAL. CANCELLOUS OR CORTICAL- CANCELLOUS BONE CHIPS FOR INCLUSION IN THE COMPOSITION OF THIS INVENTION:
  • Corticocancellous chips were processed from allograft obtained from the iliac crest, iliac crest segments and from metaphyseal cancellous bone. When metaphyseal ends and iliac crests are used, an approximate mixture of 20%:80% to about 50%:50% cortical: cancellous bone chips is obtained.
  • the bone chips are produced after debridement and antimicrobial treatment in a class 10 or class 100 cleanroom. Appropriately cleaned and sectioned bone was ground in a bone mill fitted with a sieve, to ensure that all collected bone chips are of a fairly uniform size between about 125 ⁇ m and about 5 mm.
  • the collected bone chips are in the size range of about 125 ⁇ m to about 1 mm or between about 1 mm and 3.35 mm.
  • the ground bone chips were soaked in peroxide, with sonic treatment. The peroxide treatment was repeated until no more fat or blood was visible, the peroxide was decanted and the chips were soaked in povidone iodine solution. The chips were then rinsed with water, and then soaked in an ascorbic acid solution, followed by treatment with isopropanol, with sonic treatment. Finally, the chips were treated with a further peroxide soak, followed by a water rinse, and then lyophilization. The dried chips were then sieved to select the desired size range of bone chips desired. Samples were cultured to ensure sterility.
  • a known weight of ground lyophilized gelatin of up to 850 ⁇ m particle size was mixed with a known weight of deminerahzed bone particles of between about 250 ⁇ m and 850 ⁇ m.
  • a known weight of water was added to the combined gelatin and deminerahzed bone, and thoroughly mixed.
  • the gelatin, water, deminerahzed bone composition was then warmed to form a paste of known volume, and a fifty- percent to 100 percent volume of corticocancellous bone chips of between about 125 ⁇ m and 5 mm particle size was then added and the entire composition was thoroughly mixed, with repeated warming steps as needed to ensure thorough mixing.
  • the mixed composition was then molded into desired shapes, which are stored in sealed sterile pouches or like containers. Upon use, a surgeon uses the shaped material in its pre-formed shape, or warms the material until it becomes moldable, before implanting the material into a desired implant site.

Landscapes

  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

An implant and a method for making and using the implant are disclosed for the repair of bone defects or voids, including defects or voids in the acetabular cup. The implant shapes and compositions of this invention provide advantages not present in impaction grafts and like implants known in the art.

Description

TITLE OF THE INVENTION MOLDED IMPLANTS FOR ORTHOPEDIC APPLICATIONS
BACKGROUND OF THE INVENTION
Field of the Invention:
This invention relates to an implant and methods for making and using the implant to fill void defects in bone and to accomplish orthopedic fusions.
Background Information:
In the field of orthopedics, it is desirous to be able to fill bony defects and to be able to fuse joints together using grafting procedures. One procedure that is frequently required is the repair of skeletal void defects. In particular, it is frequently required that bony defects be filled or repaired after trauma or disease has destroyed the native bone. This need may arise from trauma, as in a compound or complex fracture, through removal of diseased tissue, as in, for example, removal of a cancerous growth, or any of a number of other degenerative or damaging conditions. It is common practice in spinal surgery to effect the fusion of adjacent vertebrae by placing bone graft between the vertebrae. This need may arise from a condition such as severe scoliosis, from trauma in which the back is severely damaged, or in the common instance of degenerative disk disease.
Prior to the present invention, the filling of bone defects was usually accomplished through the use of metallic fixation and reinforcement devices or the combination of metallic devices with autograft or allograft.
Recurrent problems in the methods known in the art are the lack of incorporation of the metallic graft materials, the pain associated with autograft harvest, the lack of sufficient amounts of autograft for harvesting, the labor-intensive nature of autograft and allograft preparation, and the relatively poor performance of commonly acquired allografts.
A recurring problem in the methods known in the art for repairing, for example, the acetabular surface is that frequently, upon insertion into the acetabulum of metallic or polymeric implant materials, voids remain between the back surface of the implant and the pelvic bone remaining in the original femoral socket.
In one method known in the art, generally referred to as "impaction grafting" (see, for example, Elting, et al., Clinical Orthopaedics and Related Research, 319:159- 167, 1995), compressed morselized cancellous allograft bone is used to fashion implants for insertion, for example, into the intramedullary canal of recipients. However, problems associated with that technique include subsidence and the need to use synthetic "glues" such as polymethylmethacrylate. While cortical cancellous chips combined with metallic mesh and circlage wires have been used successfully to fill voids in the acetabulum and proximal femur, and while incorporation of bone chips and de novo bone formation at the impaction grafting site has been observed, cortical-cancellous chips handle poorly. The chips tend to behave like gravel and do not stay in the location into which they are placed unless enclosed by wire mesh or another retaining device. Furthermore, when methyl methacrylate or like cement is pressurized in impaction grafting, large amounts of bone chips become sequestered and therefore are biologically inactive.
In one recent patent, (see US Patent No. 5,824,078 and references cited therein), an apparatus was described for fashioning composite allograft by impaction of cancellous bone and added cement to form acetabular cups. These methods are limited in applicability in that the impacted implant, once formed, is no longer moldable and has limited pliability. The result of such inflexibility is that voids remain, even after the impacted graft is positioned in an appropriate location in a recipient. In addition, the impaction procedure itself requires specialized equipment (such as the rack-and-pinion device to which the 5,824,078 patent is directed) or time consuming in-surgery impaction of bone particles (see the Elting et al., article, which describes a six-step, in-situ, procedure which requires iterative packing and tamping of bone particles).
In US Patent No. 5,439,684, methods of making variously shaped pieces of deminerahzed swollen bone are disclosed. The shaped bone pieces are composed of large machined pieces of bone of specific shape and are thus not moldable and are not composed of cortical-cancellous bone chips.
This invention provides a solution to the above-noted, long-standing problems by providing specific shapes and compositions of biomaterials for filling of tissue voids, in particular in bony tissue, in an easy to use and effective format.
BRIEF DESCRIPTION OF THE DRAWINGS:
Figure 1 is a representation of a first embodiment of the invention, wherein a disk-shaped bioimplant is provided for insertion into the acetabular socket or other location to fill voids that remain upon insertion of a metallic or other implant. Figure 2 A is a representation of a second embodiment of the invention, wherein a substantially disk-shaped bioimplant is provided, but wherein a sector of the disk- shaped implant has either been removed or has not been included when initially created, so that upon insertion into the acetabluar socket, a substantially cone- shaped or hemisphere-shaped implant, figure 2B, is formed. Figure 3 provides representations of a number of further embodiments of the invention: Fig. 3 A depicts a thin "U"-shaped implant useful in knee revision surgeries; Fig. 3B depicts a thicker "U"-shaped implant useful in spinal fusion procedures; Fig. 3C depicts a thin oval implant useful in knee revision and other surgical procedures; Fig. 3D depicts an implant shape useful in posterior lumbar interbody fusion ("PLIF") procedures; Fig. 3E depicts a dowel shaped implant, useful in spinal and joint fusions; Fig. 3F depicts a tapered dowel shaped implant, useful in spinal and joint fusions.
Figure 4 provides representations of a number of further embodiments of the invention: Fig. 4A depicts a femoral or tibial ring shaped implant useful in interbody fusion procedures; Fig. 4B depicts a round, plug-shaped implant useful in cranial burr-hole repairs; Fig. 4C depicts a thin "U"-shaped implant which may be folded to provide a cone-shaped or hemisphere-shaped implant depicted in Fig. 4D, useful in knee replacement procedures; Fig. 4E depicts a thin embodiment of the implant depicted according to figure 2, and Fig. 4F depicts the implant when it is folded onto itself to form a cone or hemisphere, useful in acetabular cup reconstruction and other procedures.
Figure 5 provides representations of a number of further embodiments of the invention: Fig. 5 A depicts an implant similar to that shown in figures 2 and 4A, except that an asymmetric sector has been removed or excluded from the otherwise circular implant shape; Fig. 5B depicts the implant of Fig. 5 A when folded upon itself to form a cone, or hemisphere, useful in acetabular cup and like reconstructions; Fig. 5C depicts a "donu '-shaped implant comprising a flat circular implant having a co-axial void, useful in acetabular cup reconstruction and like procedures where the implant is molded or press-fit to the void space; Fig. 5D depicts a hemi-shell shaped implant which may be press-fit into a bone void, such as in the acetabular cup; Fig. 5E depicts a cone-shaped or hemisphere- shaped implant which may be press-fit into a bone void, such as in the acetabular cup; Fig. 5F depicts a tube which, depending on diameter, may be press-fit or used in an impaction grafting procedure in a bone intrameduUary canal; Fig. 5G depicts a nested pair of tubes or cones which may be used for repair of large femoral defects, optionally in association with impaction grafting procedures. Figure 6 provides representations of a number of further embodiments of the invention: Fig. 6 A depicts a sheet while Fig. 6B depicts a strip for repair of traumatic fractures, for cranial and flat-bone repair applications, and for inter- transverse process fusions; Fig. 6C depicts a cord-shaped implant for wrapping or grouting of severe trauma defects, for spinal fusions, inter-transverse process fusions and the like; Fig. 6D depicts a wedge-shaped implant for tibial plateau repairs, joint fusions, and intervertebral body fusions; Figs. 6E, 6F and 7 depict different embodiments of restrictive devices, useful in restricting cement or other flowable materials in plugged intrameduUary canals and the like, as in femoral canals during impaction procedures; Fig. 6G depicts an ovoid or football shaped implant useful in repairing cystoid or like bone defects; Fig. 6H depicts a hemi- ovoid or hemi-football shaped implant useful in repairing cystoid or like bone defects; Fig. 61 depicts a spherical implant useful in repairing cystoid or like bone defects; Fig. 6J depicts a hemi-spherical implant useful in repairing cystoid or like bone defects.
Figure 7 depicts an implant useful as a restrictive device for insertion into a canal, such as the intrameduUary canal of a long bone, for example during a cementous impaction procedure.
Figures 8A-C provide X-ray evidence of the efficacy of an acetabular implant according to this invention.
Figures 9A-10 provide photomicrographs of the composition of this invention, before and after implantation.
Figures 10A-D provide further photomicrographs of the composition of this invention, before and after implantation.
Figures 11A-H provides a series of photographs and X-rays showing repair of a severe tibial complex compound fracture after removal of antibiotic loaded methacrylate beads and implantation of the composition according to this invention.
Figure 12 A and 12B provide photographs of one embodiment of the implant according to this invention, and its moldability.
SUMMARY OF THE INVENTION:
This invention provides shaped implants and methods for making and using the implants to repair a wide variety of orthopedic defects or lesions, including, for example, acetabular cup damage or repair procedures. The implant may be made from any of a number of known materials, by employing the specific shapes and methods provided herein. Alternatively, specific novel compositions disclosed herein may be used for this purpose. In one embodiment of this invention, the implant is placed in the acetabular socket or other defect requiring repair, and is molded to create a perfect fit between an overlay implant to be inserted into the acetabulum and the bone surface of the pelvis or other overlay implant and basal bony structure. Accordingly, it is one object of this invention to provide a wide variety of desirably shaped implants for a wide variety of orthopedic applications.
It is another object of this invention to provide implant devices optimized in shape for repair of acetabular cup defects.
It is a further object of this invention to provide a preferred method for making a wide variety of desirably shaped implants useful in a wide variety of orthopedic applications.
It is a further object of this invention to provide a preferred method for repair of acetabular and other orthopedic defects.
It is yet a further object of this invention to provide desirably shaped implants which may be molded to create a perfect fit at the site of implantation.
Other objects and advantages of this invention will become apparent from a review of the complete disclosure and the claims appended to this disclosure.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS:
Any material having the following required characteristics may be employed to produce a device having the shapes and utilities disclosed herein. However, it will be appreciated by those skilled in the art that acceptable implant materials having the shapes and utilities disclosed herein may be prepared even though one or more of the desired characteristics is absent. Essentially, the following list of desirable characteristics would be displayed by an ideal composition, of which certain compositions are disclosed herein:
a. The composition should be bioabsorbable. b. The composition should be osteogenic. c. The composition should be osteoinductive. d. The composition should be osteoconductive. e. The composition should be malleable or flexible prior to and shortly after implantation so that any desired shape may be produced. f. The composition should be able to withstand freezing, freeze-drying or other methods of preservation and be able to withstand sterilization. g. Upon implantation, the materials should fill voids and, if malleable prior to implantation, should then set-up as a hard material in the shape of the voids that have been filled.
Those skilled in the art will appreciate that any autograft, allograft or xenograft material that is molded, machined, cast or otherwise formed into the shapes for use according to this disclosure come within the scope of this invention. However, disclosed herein are specific compositions of preferred characteristics.
Referring now to figure 1, there is provided a representation of a first embodiment 100 of a device that may be prepared and used for acetabular implantation. The device 100 is substantially disk-shaped, having an upper surface 101, a lower surface 102, each of which is substantially circular, with a diameter 110. The diameter 110 is preferably in the range between about 35 and 55 mm, and most preferably is about 45 mm. The disk 100 has a height 120, which is preferably in the range between about 1 mm and about 10 mm, and is most preferably about 5 mm in height. Furthermore, the disk 100 may be composed of particulate matter 130 embedded or suspended in a base or carrier material 140. The particulate matter may be collagen sponge, cortical bone chips, cancellous bone chips, cortico-cancellous bone chips, hydroxyapatite or like ceramics, bioactive glass, growth factors, including but not limited to bone morphogenetic protein, PDGF, TGFβ, cartilage-derived morphogenetic proteins (CDMPs), vascular growth factors, and the like, deminerahzed bone, or any other material considered to be beneficial in the filling of bone or cartilaginous voids and the remodeling thereof into solid, healthy bone or cartilage through the processes of osseointegration (including osteogenesis, osteoinduction, or osteoconduction, as these terms are recognized in the art). The base or carrier material 140 may be any material, which retains a given form upon implantation into the void being filled behind an acetabular implant or in any other orthopedic application. Thus, for example, fibrin-containing compositions, which coagulate, may be included in the carrier material 140, as may be various collagen formulations, hydroxylapatite, pleuronic polymers, natural or synthetic polymers, or carboxymethylcellulose, and combinations thereof. Preferably, the carrier material 140 comprises a sufficiently high concentration of gelatin, derived from human or animal tissue, or transgenic sources, such that prior to or upon implantation, the gelatin sets up to form a solid or semi-solid material of the desired shape. Use of gelatin as the base carrier material is considered desirable because, by simply heating a pre-formed device according to any of the embodiments of this invention, the implant device becomes flexible or malleable, and may be caused to precisely fit into the shape of any existing void or defect.
Where gelatin is employed as the base or carrier material, and cortical, cancellous or cortico-cancellous bone chips or deminerahzed bone is included in the carrier, the following percentages, on a weight basis, are considered desirable for formation of the variously shaped implants disclosed herein: the gelatin is preferably present at between about 12 to 27 weight percent. Deminerahzed bone is preferably present at between about 15 to 33 weight percent. Finally, cancellous bone chips, cortical bone chips or cortico-cancellous bone chips are preferably present at between about 70 to 100 volume percent. The bone chips soak up the gelatin/demineralized bone material so that approximately equal volumes of the gelatin/demineralized bone and bone chips are preferably combined to produce the final preferred composition. Devices formed from this composition meet all of the requirements of a desirable implant material set forth above. Naturally, those skilled in the art will appreciate that a wide variety of supplemental constituents may be included in the composition. Thus, for example, growth factors, antibiotics, anti-inflammatory or other biologically active agents may be included at percentages that may be defined through routine experimentation, so long as the basic properties of the implant material is not adversely affected.
Using the appropriate concentration of gelatin, deminerahzed bone (to provide osteogenic factors) and cortical-cancellous bone chips (to provide structural strength and bone void filling capacity), a composition that is malleable above body temperature may be produced. Upon implantation or upon cooling, a solid device forms which may be machined or warmed for molding into any desired shape.
Referring now to figure 2A, there is shown a further embodiment 200 of the device according to this invention. This device is similar to that shown in figure 1, in that it has an upper surface 201, a lower surface 202, both of which are substantially circular. However, from this embodiment of the invention, a sector 203 has been removed or has not been included in the formation of the device, resulting in what will be referred to herein as a "filled-C-shape". The purpose of this design modification is discussed in connection with the description of figure 2B below. The composition of the device shown in figure 2A and that of figure 1 may be similar, as are its desirable characteristics. The diameter 210 of the device 200 is preferably between about 50 mm and about 150 mm, and is most preferably between about 75 mm and 90 mm. The height 220 of the device is between about 1 mm and about 10 mm, and is most preferably about 5 mm. In addition, the particulate materials 230, when included, are similar to the particulate materials 130. The base or carrier material 240 is likewise similar to the carrier or base material 140. The angle formed between the adjacent sides 204 and 205 of the device 200 that exist by virtue of the absent sector 203 may be any angle greater than zero degrees and less than three-hundred and sixty degrees, and is preferably between about 90 and 150 degrees, and is most preferably about 120 degrees.
In figure 2B, there is shown the device 200, wherein the adjacent sides 204 and 205 have been brought into contact, to form a substantially cone-shaped or hemisphere-shaped implant 260. Desirably, the device retains thermoplastic behavior for a limited amount of time after formation, so that the desired shape may be formed from the cone-shaped implant 260.
Based on the foregoing disclosure, it will be apparent to one skilled in the art that a wide variety of shapes and orthopedic applications may be addressed according to this invention. As examples of the wide- variety of applications and shapes that may be addressed by this invention, reference is made to figures 3 through 7 included with this disclosure. Thus, Figure 3 provides representations of a number of further embodiments of the invention: Fig. 3 A depicts a thin "U"- shaped implant 300 useful in knee revision surgeries. Fig. 3B depicts a thicker "U"-shaped implant 310 useful in spinal fusion procedures. Fig. 3C depicts a thin oval implant 320 useful in knee revision and other surgical procedures. Fig. 3D depicts an implant shape 330 useful in posterior lumbar interbody fusion ("PLIF") procedures. Fig. 3E depicts a dowel shaped implant 340, useful in spinal and joint fusions. Fig. 3F depicts a tapered dowel shaped implant 350, useful in spinal and joint fusions. According to the methods disclosed above, various percentages of particulate materials may be included in each of these disclosed shapes, as defined by routine experimentation, for particular applications. In addition, methods for conducting posterior lumbar interbody fusions, spinal fusions induced by dowels and the like may be carried out according to methods known in the art, but using the novel devices disclosed herein.
Further examples of implant shapes that may be produced and used according to the present disclosure are depicted in Figure 4. Thus, Fig. 4A depicts a femoral or tibial ring shaped implant 400 useful in interbody fusion procedures. Fig. 4B depicts a round, plug-shaped implant 410 useful in cranial burr-hole repairs. Fig. 4C depicts a thin "U"-shaped implant 420 which may be folded to provide a cone- shaped or hemisphere-shaped implant 430 depicted in Fig. 4D, useful in knee replacement procedures. Fig. 4E depicts a thin embodiment 440 of the implant depicted according to figure 2, and Fig. 4F depicts the implant 450 when it is folded onto itself to form a cone, or hemisphere, useful in acetabular cup reconstruction and other procedures.
Additional examples of implant shapes that may be produced and used according to the present disclosure are depicted in Figure 5. Thus, Fig. 5A depicts an implant 510 similar to that shown in figures 2 and 4A, except that an asymmetric sector 511 has been removed or excluded from the otherwise circular implant shape. Fig. 5B depicts the implant of Fig. 5 A when folded upon itself to form a cone or hemisphere 520, useful in acetabular cup and like reconstructions. Fig. 5C depicts a "donu '-shaped implant 530 comprising a flat circular implant having a co-axial void, useful in acetabular cup reconstruction and like procedures where the implant is molded or press-fit to the void space. Fig. 5D depicts a hemi-shell shaped implant 540 which may be press-fit into a bone void, such as in the acetabular cup. Fig. 5E depicts a cone-shaped or hemisphere-shaped implant 550, which may be press-fit into a bone void, such as in the acetabular cup. Fig. 5F depicts a tube 560 which, depending on diameter, may be press-fit or used in an impaction grafting procedure in a bone intrameduUary canal. Fig. 5G depicts a nested pair of tubes or cones 570, which may be used for repair of large femoral defects, optionally in association with impaction grafting procedures. Each of these shapes may be fashioned by hand, molded, extruded or formed by other means known in the art. In addition, solid materials may be machined to produce the desired shapes, or because of the thermoplastic properties of gelatin, the desired shapes may be produced by known stereolitho graphic processes.
Yet further examples of the shapes that may be produced and used according to this invention are depicted in Figure 6. Thus, Fig. 6A depicts a sheet 600 while Fig. 6B depicts a strip 610 for repair of traumatic fractures, for cranial and flat- bone repair applications, and for inter-transverse process fusions. Fig. 6C depicts a cord-shaped implant 620 for wrapping or grouting of severe trauma defects, for spinal fusions, inter-transverse process fusions and the like. Fig. 6D depicts a wedge-shaped implant 630 for tibial plateau repairs, joint fusions, and intervertebral body fusions; Figs. 6E, 6F and 7 depict different embodiments of restrictive devices, 640, 650, 700, useful in restricting cement or other flowable materials in plugged intrameduUary canals and the like, as in femoral canals during impaction procedures. The flow restrictor 640 has a classic "cork" stopper shape. The implant 650 has a tapered shape like that of the "cork" 640, but the device 650 is formed by a plurality of stacked "ribs" 651-655 of decreasing diameter. Naturally, the ribs may be formed by molding, such that separate elements 651-655 need to be separately produced. The implant 700 comprises an upper, solid portion 710 having a substantially "cork" shaped configuration. Affixed at seam 720 to the upper solid portion 710 is a thin, hollow, lower portion 730. The thin lower portion 730 folds upward about seam 720 upon insertion of the implant 700 into a lumen 780 of a bone 790 to form a tight seal 740 surrounding the upper plug portion 710. Fig. 6G depicts an ovoid or football shaped implant 660 useful in repairing cystoid or like bone defects. Fig. 6H depicts a hemi-ovoid or hemi-football shaped implant 670 useful in repairing cystoid or like bone defects. Fig. 61 depicts a spherical implant 680 useful in repairing cystoid or like bone defects. Fig. 6J depicts a hemi-spherical implant 690 useful in repairing cystoid or like bone defects.
Having generally described the invention, including the best mode and preferred embodiments thereof, the following section provides specific exemplary support for the invention as disclosed and claimed. However, the specifics of these examples are not to be considered as limiting on the general aspects of this invention as disclosed and claimed.
Example 1 : REPAIR OF AN ACETABULAR CUP DEFECT:
A patient presents with a severe osteolytic lesion behind a primary acetabular implant, due to wear-debris induced osteolysis. In this case, a revision surgery was indicated to replace the worn acetabular component and to remove the lesion. After removing the original acetabular component, the bone lesion was curetted out leaving a healthy bleeding bone mass. A cone- or hemisphere-shaped device was made from 100% v/v cortical-cancellous chips mixed with 68% v/v deminerahzed bone matrix in a gelatin carrier (24% w/w deminerahzed bone matrix, 26% w/w gelatin, 50% w/w water) was heated to soften the implant, which was then folded to form a cone or hemisphere. This softened cone or hemisphere of allograft was then forced into the curetted lesion and compressed with the fingers or a trial acetabular cup. A trial cup or a reamer was used to shape the allograft into the form of the back of the new acetabular component. Once the material hardened, the new acetabular component was placed on top of the allograft cup and screwed into place. The resulting efficacy is plainly evident in a series of X-rays of a patient that underwent this procedure. See figure 8. Figure 8 A shows the pre-operative condition of an implant in which the osteolytic defect surrounding the implant articulating surface is clearly evident as the absence of bone mass in the X-ray. Figure 8B shows an immediate post-operative X-ray, showing the implant with the above-described composition located where the osteolytic defect existed. Figure 8C shows the same patient six months after completion of the osteolytic defect repair operation. Growth of new bone and repair of the defect is clearly evident. Example 2: PLACEMENT OF A PRIMARY HIP ACETABULAR CUP:
Press-fit implants are used in younger patients because the long-term success of these implants is improved over those that are cemented into place using methacrylate bone cement. The reason for this improved long-term success is that the bone directly bonds to the surface of the implant. Because bone-to-implant bonding is improved by the incorporation of a porous coat in the implant, most press-fit orthopedic implants now have a porous coating. However, even with a porous coating, after explantation, most implants are found to only have bonded to the bone over approximately 20% of the surface area. Research has also shown that the long-term success of the implant is roughly correlated with degree of host- implant bonding. The degree of host-implant bonding is severely affected by the quality of the fit between the bone and the implant. If there is too much play in the bone-implant fit, then little or no bonding occurs and it will be necessary to cement the implant into place. By contrast, the osteoinductive, osteoconductive or osteogenic matrix according to this invention, which closely and concurrently interdigitates with both the porous surface of the implant and the bone into which the implant is inserted, facilitates repair of even poorly cut cavities in bone for press-fit insertion of implants. Interdigitation between the porous implant surface and bone causes bone to be induced or conducted from the bleeding bone into the porous coating and thereby induce much better bone-implant bonding. Bearing these considerations in mind, a young, otherwise healthy, patient presenting with osteoarthritis of the hip is treated as follows: It is noted that the degree of advancement of osteoarthritic bone destruction is such that drug-therapy is insufficient to relieve pain and the patient has limited mobility. In this case, a primary press-fit hip replacement is indicated. Through standard surgical techniques, the natural hip is removed and prepared for replacement with a metallic hip. The acetabulum is prepared by carefully reaming out a space that fits to the back of the acetabulum. A doughnut-shaped acetabular implant (Fig. 4 A or 5C) is prepared by warming in a water bath. The warm doughnut-shaped implant is placed into the patient's prepared acetabulum. While the doughnut-shaped implant is still warm, the porous acetabular cup is placed on top of the doughnut- shaped implant and is hammered into place. The particle size and viscosity of the doughnut- shaped implant material allows the material to easily flow into the porous coating of the implant and into the host's cancellous bone.
Figure 9A shows a photomicrograph (40-X) of stained (H&E) composition according to this invention. Based on the staining, the different components of this composition are identified. Note the preferred relative uniformity, preferably between about 125 μm to about 5mm, and preferably, between about 500 μm to about 1 mm or between about 1mm to about 3.35 mm. We have found that bone chips uniformly formed within these preferred size ranges result in surprisingly improved induction and conduction of new bone formation and improved handling of the composition. In figure 9B, the same material is viewed under higher magnification (100X), showing the interpenetration of gelatin into and onto the cortical-cancellous chips and deminerahzed bone matrix of the composition. Figure 9C shows a biopsy after implantation of this composition in a human female, 6 months after implantation, showing new bone formed onto the surface of a piece of allograft (H&E, 100X). Noticeable are the numerous cutting cones within the mineralized allograft, indicating that the allograft bone will continue to be fully remodeled over time. Figure 9D shows a biopsy of new woven bone between mineralized allograft chips (H&E, 100X). It should be noted that the area between the spicules would normally be filled with healthy marrow. However, in this case, it can be seen that these areas are filled with fibrous inflammatory tissue cause by wear debris from a failed prosthesis. Figure 10A shows additional photomicrographs of a biopsy from a human female six months after implantation of the composition of this invention. This photograph shows details of a cutting cone in a piece of mineralized allograft (H&E, 400X), revealing the presence of osteoclasts, osteoblasts and a cement line, whereby implant material is remodeled into normal healthy recipient bone. Figure 10B shows a detailed photomicrograph of a cement line between mineralized allograft and new bone (H&E, 400X), revealing osteoblasts at the periphery of the allograft. Figure IOC is a photomicrograph of normal marrow found in areas adjacent newly formed bone, unaffected by wear debris (H&E, 400X). Figure 10D provides a detail of the filamentous wear debris found in the fibrous inflammatory tissue (H&E, 400X).
These photomicrographs clearly demonstrate that the composition of this invention, whether provided in a pre-formed shape, or molded to fit precisely into a recipient implant site, results in rapid remodeling and osteoinductive and osteoconductive effects. Accordingly, gaps that might otherwise prevent new bone formation and ingrowth may be filled with the composition of this invention to induce union between bone and implant materials. Thus, in one specific embodiment of this invention, a porous implant or an implant having a porous coating is contacted with the composition according to this invention. For example, in a total knee arthroplasty, typically an implant having 500-700 μm metal beads contacted with the sawn-off end of the femur. By application of the composition of this invention at the union surface, rapid ingrowth of bone into the metal bead interstices is induced by driving the implant surface into a pre-formed or molded shape formed from the composition according to this invention.
Example 3: REPAIR OF A COMPLEX COMPRESSION FRACTURE:
Complex compression fractures are frequently associated with significant bone loss because the nature of the fracture is such that the bone is shattered and many of the bone fragments are irretrievable. Current practice dictates the collection of as many bone pieces as possible and the placement of those pieces back into the fracture site. Missing pieces are normally replaced with morselized autograft taken from the hip, from the rib, or from the fibula. Occasionally, artificial grafting materials are used with limited success. AUografts have also been used, with varying success, largely dependent upon the nature of the allograft and its source. The application of malleable or moldable pre-formed and appropriately- shaped implants to this type of repair allows the surgeon to effectively replace the lost bone, without inducing additional trauma by harvesting autograft from another surgical site.
Accordingly, a complex fracture, such as one in the radius, is repaired by following standard surgical techniques to clean the fracture site followed by placement within the fracture of malleable allograft implant material of this invention in the form of a football, sphere, hemi-football, hemisphere, or sheet/strip. Shattered bone particles are packed around the malleable material. Alternatively, the shattered particles of bone are placed into the fracture site and then strips or cords of malleable implant material according to this invention are laid over the fracture site. Malleable cord-shaped implant material of this invention is optionally used as an adjunct or in place of circlage wires to fix the fracture fragments into place.
Figure 11 shows a surgical procedure in a tibia of a patient who experienced a complex compound fracture into which, for a period of four weeks, had been implanted gentamycin impregnated polymethylmethacrylate "beads on a string". Figure 11 A shows circular structures in the center of the photograph which are the beads, implanted in an effort to treat a local infection at a fracture site. Figure 1 IB shows a pre-operative X-ray of the surgical set-up, again with the implanted beads visible in the bone void. Figure 11C shows the intra-operative procedure whereby the implanted beads were removed. Figure 1 ID shows the large cavity remaining after removal of the beads. Figure 1 IE shows a photograph of the composition according to this invention, formed in the shape of two dry eight cubic centimeter disks, prior to implantation. Figure 1 IF is an intra-operative photograph, after implantation of sixteen cubic centimeters of the composition of this invention. The implant material is clearly visible, and as can be seen from this photograph, is moistened by body fluids, but is not soluble and is not washed away. Figure 11G shows the implant site immediately post-implantation. The site of the implant within the void can be discerned as a faint cloud within the void. Figure 11H is an X-ray photograph of the implant site six-weeks post implantation. It can clearly be seen that the implant material has remodeled to form solid bone mass, while a portion of the void into which implant material was not or could not be implanted remains a void.
Example 4: REPAIR OF OSTEOLYTIC CYSTS:
Osteolytic cysts and other growths on bone that must be removed are typically difficult to replace. Traditional practice dictates that large cystic defects be filled with weight- bearing allograft or autograft. Alternative techniques have employed synthetic materials with limited success.
In this application of the malleable implant material of this invention, cystic defects are repaired after removal of the cyst by placing warm, malleable implant material according to this invention onto the defect and forming it to completely fill the void. The material according to a preferred embodiment of this invention remodels into natural bone in a period ranging from between about 6 weeks to about 9 months.
Example 5: INTERTRANSVERSE PROCESS SPINAL FUSION:
Intertransverse process spinal fusion is generally accomplished by the joint application of both metallic fixation devices and the use of autograft, which is generally harvested from the patient's hip. The autograft harvest is associated with a high rate of morbidity (21%). The use of a grafting material that is effective without the necessity of harvesting autograft would greatly benefit patients in need of such procedures.
Accordingly, after standard surgical preparation including rigorous decortication of the transverse processes and the facets of two adjoining vertebrae, a malleable pre-molded form (strips or cords) of the malleable implant material of this invention are lain gutter alongside the vertebral bodies. Local bone reamings are optionally mixed or intermingled with the still warm and malleable implant material and then the implant material is pressed into the bleeding bone bed. Example 6: FILLING OF CRANIAL BURR HOLES:
Cranial burr-holes are created whenever it is necessary to cut into the skull in order to gain access to the brain. Current technique dictates the use of plaster of paris-like substances, metallic meshes, and bone waxes to fill these holes, or to not fill them at all. None of the commonly employed products and procedures induce bone to grow across the defect, and some of these products and procedures actually inhibit the growth of the bone.
Accordingly, in this application, a disk-shaped piece of pre-molded implant material according to this invention is placed, warm, into the burr-hole defect, with a small lip of the implant material remaining above the surface to serve as a temporary support for the material. It is anticipated that the temporary support is unnecessary after a period of several days, after which the plug is expected to remain in place on its own. It is anticipated that new bone grows into the remaining gap to completely bridge the gap within about 6 weeks to about 9 months.
Example 7: MOLDING OF THE COMPOSITION OF THIS INVENTION:
Figure 12 shows the formability and moldability of the composition of this invention. Figure 12A shows a dry cone or hemisphere of the composition. Upon hydration and heating to about 43 to about 49 degrees centigrade, the material becomes moldable, and re-sets at body temperature, as shown in figure 12B, where the moldable material is being press-fit by finger pressure into a cavity. Once set-up, the material is easily reamed or drilled for placement of any desired prosthesis. Example 8: PRODUCTION OF CORTICAL. CANCELLOUS OR CORTICAL- CANCELLOUS BONE CHIPS FOR INCLUSION IN THE COMPOSITION OF THIS INVENTION:
Corticocancellous chips were processed from allograft obtained from the iliac crest, iliac crest segments and from metaphyseal cancellous bone. When metaphyseal ends and iliac crests are used, an approximate mixture of 20%:80% to about 50%:50% cortical: cancellous bone chips is obtained. The bone chips are produced after debridement and antimicrobial treatment in a class 10 or class 100 cleanroom. Appropriately cleaned and sectioned bone was ground in a bone mill fitted with a sieve, to ensure that all collected bone chips are of a fairly uniform size between about 125 μm and about 5 mm. Preferably, the collected bone chips are in the size range of about 125 μm to about 1 mm or between about 1 mm and 3.35 mm. The ground bone chips were soaked in peroxide, with sonic treatment. The peroxide treatment was repeated until no more fat or blood was visible, the peroxide was decanted and the chips were soaked in povidone iodine solution. The chips were then rinsed with water, and then soaked in an ascorbic acid solution, followed by treatment with isopropanol, with sonic treatment. Finally, the chips were treated with a further peroxide soak, followed by a water rinse, and then lyophilization. The dried chips were then sieved to select the desired size range of bone chips desired. Samples were cultured to ensure sterility.
Example 9: PREPARATION OF THE COMPOSITION OF THIS INVENTION FOR MOLDING INTO DESIRED SHAPES:
A known weight of ground lyophilized gelatin of up to 850μm particle size was mixed with a known weight of deminerahzed bone particles of between about 250μm and 850μm. A known weight of water was added to the combined gelatin and deminerahzed bone, and thoroughly mixed. The gelatin, water, deminerahzed bone composition was then warmed to form a paste of known volume, and a fifty- percent to 100 percent volume of corticocancellous bone chips of between about 125μm and 5 mm particle size was then added and the entire composition was thoroughly mixed, with repeated warming steps as needed to ensure thorough mixing. The mixed composition was then molded into desired shapes, which are stored in sealed sterile pouches or like containers. Upon use, a surgeon uses the shaped material in its pre-formed shape, or warms the material until it becomes moldable, before implanting the material into a desired implant site.

Claims

WHAT IS CLAIMED IS:
1. An implant for repair of bone voids or defects, wherein said implant exhibits the following characteristics: a. the implant composition is bioabsorbable; b. the implant composition is osteogenic; c. the implant composition is osteoinductive; d. the implant composition is osteoconductive; e. the implant composition is malleable prior to and shortly after implantation so that any desired shape may be produced to exactly conform to the shape of the implant site; and f. the implant composition is able to withstand freezing, freeze-drying, and sterilization.
2. The implant according to claim 1 wherein said implant is implanted in the form of a pre-formed shape, or is molded to form a new shape or is molded in-situ upon implantation, to fill voids, such that said implant sets-up as a hard material in the shape of the voids that have been filled.
3. The implant according to claim 2 comprising a base or carrier material which comprises a sufficiently high concentration of gelatin, derived from human or animal tissue, such that prior to or upon implantation, the gelatin sets up to form a solid or semi-solid material of the desired shape.
4. The implant according to claim 3 further comprising cortical, cancellous or cortico-cancellous bone chips or deminerahzed bone.
5. The implant according to claim 4 wherein said bone chips are between about 125μm and about 5 mm in size.
6. The implant according to claim 5 wherein said bone chips are between about 500μm and about 1 mm in size.
7. The implant according to claim 5 wherein said bone chips are between about 1mm and 3.35 mm in size.
8. The implant according to claim 4 comprising, on a weight basis, a first component comprising: gelatin at between about 12 to 27 weight percent, deminerahzed bone at between about 15 to 33 weight percent, and the balance water, and a second component comprising: cortical bone chips, cancellous bone chips, or cortico-cancellous bone chips at a volume ratio of about 70 to 100 percent that of the combined gelatin/demineralized bone, said composition optionally including growth factors, antibiotics, anti-inflammatory or other biologically active agents.
9. The implant according to claim 1 comprising a disk shaped implant, a filled-C-shaped implant, a cone- or hemisphere-shaped implant, a U- shaped implant, a dowel or tapered-dowel shaped implant, donut-shaped implant, a filled-C-shaped implant having an asymmetric sector shaped space, a cup-shaped implant, a tube shaped implant, a sheet or strip-shaped implant, a cord-shaped implant, a wedge-shaped implant, a cork-shaped implant, a rib-shaped implant, a football-shaped implant, a hemi-football shaped implant, a sphere shaped implant, a hemi-sphere shaped implant, or an implant comprising an upper, cork-shaped segment, a seam and a lower hollow cone- or hemisphere-shaped segment.
10. The implant according to claim 1 when used in repair of an acetabular cup defect.
11. The implant according to claim 10 comprising a substantially disk-shaped device 100, having an upper surface 101, a lower surface 102, each of which is substantially circular, with a diameter 110, and a height 120.
12. The implant according to claim 11 wherein the diameter 110 is in the range between about 35 and 55 mm.
13. The implant according to claim 12 wherein said diameter 110 is about 45 mm.
14. The implant according to claim 11 wherein said height 120 is in the range between about 1 mm and about 10 mm.
15. The implant according to claim 14 wherein said implant height 120 is about 5 mm.
16. The implant according to claim 11 wherein the disk 100 is composed of particulate matter, 130 embedded or suspended in a base or carrier material 140.
17. The implant according to claim 16 wherein said particulate matter 130 is composed of collagen sponge, cortical bone chips, cancellous bone chips, cortico-cancellous bone chips, hydroxyapatite or like ceramics, bioactive glass, growth factors, bone morphogenetic protein, PDGF, TGFβ, vascular growth factors, deminerahzed bone, or combinations thereof.
18. The implant according to claim 17 wherein the base or carrier material 140 retains a given form upon implantation into a void space behind an acetabular implant.
19. The implant according to claim 18 wherein said carrier material 140 comprises fibrinogen, collagen, gelatin, hydroxylapatite, pleuronic polymers, natural or synthetic polymers, or carboxymethylcellulose, and combinations thereof.
20. The implant according to claim 1 comprising an upper surface 201, a lower surface 202, both of which are substantially circular, but wherein a sector 203 has been removed or has not been included in the formation of the device, resulting in a device having a "filled-C-shape", an angle 250 formed between adjacent sides 204 and 205 that exist by virtue of the absent sector 203, a diameter 210, and a height 220.
21. The implant according to claim 20 wherein the diameter 210 is between about 50 mm and about 150 mm.
22. The implant according to claim 21 wherein the diameter 210 is between about 75 mm and about 90 mm.
23. The implant according to claim 20 wherein the height 220 of the device is between about 1 mm and about 10 mm.
24. The implant according to claim 23 wherein said height 220 is about 5 mm.
25. The implant according to claim 20 comprising particulate material 230 composed of collagen sponge, cortical bone chips, cancellous bone chips, cortico-cancellous bone chips, hydroxyapatite or like ceramics, bioactive glass, growth factors, bone morphogenetic protein, TGFβ, PDGF, vascular growth factors, deminerahzed bone, and combinations thereof.
26. The implant according to claim 20 comprising a base or carrier material 140 which retains a given form upon implantation into a void space behind an acetabular implant.
27. The implant according to claim 26 wherein said carrier material 140 comprises fibrinogen, collagen, gelatin, hydroxylapatite, pleuronic polymers, natural or synthetic polymers, or carboxymethylcellulose, and combinations thereof.
28. The implant according to claim 20 wherein the angle 250 formed between the adjacent sides 204 and 205 is greater than 0 and less than 360 degrees.
29. The implant according to claim 28 wherein the angle 250 formed between the adjacent sides 204 and 205 is between about 90 degrees and 180 degrees.
30. The implant according to claim 29 wherein said angle 250 is about 120 degrees.
31. The implant according to claim 20 formed in the shape of a cone or hemisphere by bringing the adjacent sides 204 and 205 into contact.
32. The implant according to claim 1 comprising an implant selected from the group consisting of: a thin "U"-shaped implant 300 useful in knee revision or primary press-fit surgeries; a thicker "U"-shaped implant 310 useful in spinal fusion procedures; a thin oval implant 320 useful in knee revision or primary press-fit and other surgical procedures; an implant shape 330 useful in posterior lumbar interbody fusion ("PLIF") procedures; a dowel shaped implant 340, useful in spinal and joint fusions; a tapered dowel shaped implant 350, useful in spinal and joint fusions; a femoral or tibial ring shaped implant 400 useful in interbody fusion procedures; a round, plug-shaped implant 410 useful in cranial burr-hole repairs; a thin "U"- shaped implant 420 which may be folded to provide a cone- or hemisphere-shaped implant 430, useful in knee replacement procedures; a thin implant 440 comprising a substantially circular shape and a void section, which may be folded onto itself to form a cone or hemisphere 450, useful in acetabular cup reconstruction and other procedures; a substantially circular implant 510 comprising an asymmetric sector 511 which may be folded upon itself to form a cone or hemisphere 520, useful in acetabular cup and like reconstructions; a "donu '-shaped implant 530 comprising a flat circular implant having a co-axial void, useful in acetabular cup reconstruction and like procedures where the implant is molded or press-fit to the void space; a hemi-shell shaped implant 540 which may be press-fit into a bone void, such as in the acetabular cup; a cone-or hemisphere-shaped implant 550 which may be press-fit into a bone void, such as in the acetabular cup; a tube 560 which, depending on diameter, may be press-fit or used in an impaction grafting procedure in a bone intrameduUary canal; a sheet 600 for repair of traumatic fractures, for cranial and flat-bone repair applications, and for inter-transverse process fusions; a strip 610 for repair of traumatic fractures, for cranial and flat- bone repair applications, and for inter- transverse process fusions; a cord- shaped implant 620 for wrapping or grouting of severe trauma defects, for spinal fusions, inter-transverse process fusions; a wedge-shaped implant 630 for tibial plateau repairs, joint fusions, and intervertebral body fusions; a restrictive devices, 640, 650, 700, useful in restricting cement or other flowable materials in plugged intrameduUary canals and the like, as in femoral canals during impaction procedures; an ovoid or football shaped implant 660 useful in repairing cystoid or like bone defects; a hemi-ovoid or hemi-football shaped implant 670 useful in repairing cystoid or like bone defects; a spherical implant 680 useful in repairing cystoid or like bone defects; and a hemi-spherical implant 690 useful in repairing cystoid or like bone defects.
33. The implant 650 according to claim 32 comprising a tapered, cork-like shape formed by a plurality of stacked "ribs" 651-655 of decreasing diameter.
34. The implant 700 according to claim 32 comprising an upper, solid portion 710 having a substantially "cork" shaped configuration, to which is affixed at seam 720 is a hollow, lower portion 730 which folds upward about seam 720 upon insertion of the implant 700 into a lumen 780 of a bone 790 to form a tight seal 740 surrounding the upper plug portion 710.
35. A method of repairing a bone defect or void which comprises implanting therein an implant which exhibits the following characteristics: a. the implant composition is bioabsorbable; b. the implant composition is osteo genie; c. the implant composition is osteoinductive; d. the implant composition is osteoconductive; e. the implant composition is malleable prior to and shortly after implantation so that any desired shape may be produced to exactly conform to the shape of the implant site; f. the implant composition is able to withstand freezing, freeze-drying, and sterilization; and g. upon implantation, the implant material fills voids and then sets-up as a hard material in the shape of the voids that have been filled.
36. A method for inducing bone ingrowth into a porous implant or an implant comprising a porous coating which comprises contacting the surface of said implant with an implant according to claim 1.
37. A method for inducing bone ingrowth into an implant having multiple metal beads intended for contact with a cut bone surface which comprises contacting said metal beads of said implant with an implant according to claim 1 such that said implant fills voids between said metal beads.
38. The method according to claim 37 wherein said implant is an implant used in total knee arthroplasty.
39. A method for making the implant according to claim 1, which comprises combining between one half to about an equal volume of a first composition comprising cortical bone chips, cancellous bone chips, or cortical-cancellous bone chips to a second component comprising gelatin, deminerahzed bone and water.
40. The method according to claim 39 which further comprises warming said combined first and second components, such that said combined components become intimately mixed and moldable, molding said combined components to form a desired shape, and cooling said combined and molded shape such that said combined components solidify in the form of said desired shape.
EP00917954A 1999-03-16 2000-03-14 Molded implants for orthopedic applications Withdrawn EP1181060A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US26881299A 1999-03-16 1999-03-16
US268812 1999-03-16
PCT/US2000/006773 WO2000054821A1 (en) 1999-03-16 2000-03-14 Molded implants for orthopedic applications

Publications (1)

Publication Number Publication Date
EP1181060A1 true EP1181060A1 (en) 2002-02-27

Family

ID=23024589

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00917954A Withdrawn EP1181060A1 (en) 1999-03-16 2000-03-14 Molded implants for orthopedic applications

Country Status (3)

Country Link
EP (1) EP1181060A1 (en)
CA (1) CA2367376A1 (en)
MX (1) MXPA01010415A (en)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO0054821A1 *

Also Published As

Publication number Publication date
MXPA01010415A (en) 2002-05-06
CA2367376A1 (en) 2000-09-21

Similar Documents

Publication Publication Date Title
WO2000054821A1 (en) Molded implants for orthopedic applications
AU2001275999B2 (en) Osteoimplant and method of making same
US9999520B2 (en) Osteoimplant and method of making same
US7837740B2 (en) Two piece cancellous construct for cartilage repair
CA2363153C (en) Load-bearing osteoimplant, method for its manufacture and method of repairing bone using same
US8795361B2 (en) Osteochondral plug graft, kit and method
US20050010304A1 (en) Device and method for reconstruction of osseous skeletal defects
JP2011036690A (en) Bone graft composite material and spacer
US20080133008A1 (en) Cartilage repair mixture containing allograft chondrocytes
US20090043389A1 (en) Cartilage implant plug with fibrin glue and method for implantation
AU2001275999A1 (en) Osteoimplant and method of making same
WO2001008714A1 (en) Cartilage or bone matrix as a nucleic acid delivery vehicle
US20100049326A1 (en) Joint revision implant
AU6499700A (en) Reduced antigenicity tissue (rat) implants
EP1181060A1 (en) Molded implants for orthopedic applications
Yang et al. Bone grafts and bone graft substitutes
Delloye et al. Impaction bone grafting in revision arthroplasty
Schimmel Acetabular reconstruction with impacted morsellized cancellous bone grafts in cemented revision hip arthroplasty
US20120259425A1 (en) Precision Shaped Compressed Demineralized Cancellous Bone Product and Method to Make Same

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011004

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20031001